C

Corcept Therapeutics

CORT

37.970
USD
-0.71
(-1.84%)
Market Closed
Volume
33,982
EPS
0
Div Yield
0
P/E
43
Market Cap
5,132,670,077
Related Instruments
A
ACAD
-0.020
(-0.11%)
19.000 USD
A
ALNY
31.19
(13.13%)
268.66 USD
AMGN
2.78
(0.84%)
335.22 USD
B
BMRN
0.270
(0.32%)
84.620 USD
E
EXEL
0.740
(3.15%)
24.200 USD
GILD
0.470
(0.62%)
76.510 USD
I
INCY
-0.680
(-1.05%)
64.390 USD
REGN
13.14
(1.22%)
1,091.19 USD
S
SRPT
1.650
(1.16%)
144.000 USD
VRTX
9.75
(1.97%)
505.40 USD
News

Title: Corcept Therapeutics

Sector: Healthcare
Industry: Biotechnology
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.